• Home
  • Kenzi Riboulet-Zemouli
Kenzi Riboulet-Zemouli

Kenzi Riboulet-Zemouli
Independent researcher

Independent researcher
International drug control

About

49
Publications
49,317
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
26
Citations
Introduction
Barcelona-based, French-Algerian interdisciplinary researcher. Action-research on alternative law and policy approaches to cannabis and other controlled plants, fungi, products, and substances –linking international law and relations with local concerns and grassroots initiatives. Ethics, human rights, fair trade, sustainability, internationalism. ORCID 0000-0003-2761-1533

Publications

Publications (49)
Article
Full-text available
Objective: Identify a coherent nomenclature of products containing cannabinoids (whether derived from Cannabis sativa L. or not). Design: Research undertaken in parallel to the three-year assessment of Cannabis derivatives by the World Health Organisation. The scope is limited to Cannabis products intended for human incorporation (internal and to...
Research
Full-text available
In the current legal landscape, it is possible to craft policy that combats drug abuse and drug harms, protects human rights, and complies with international drug control law in good faith, by regulating the recreational uses of cannabis products rather than outlawing them. This essay proposes exactly that solution. The international drug control C...
Article
To read the accepted manuscript, go to: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4055389 ––– Background: “Cannabis” and “cannabis resin” are derived from the Cannabis plant, used as herbal medications, in traditional medicine and as active pharmaceutical ingredients. Since 1961, they have been listed in Schedule IV, the most restrictive...
Preprint
Full-text available
Background: In 2016-2019, the WHO Expert Committee on Drug Dependence scientifically reviewed cannabis products. In that context, multiple references to a previous and similar assessment dating back to 1935 were made; but the content, outcome, and stakeholders involved in the 1935 review were unclear. Method: Transnational historiography of the int...
Book
Full-text available
A comprehensive toolkit –for decisionmakers, scholars, advocates, amateurs, and open minds– to understand why an appropriate policy address to cannabis is critical if we are to achieve sustainable, resilient, fair, and modern societies. Updated and extended version of the previous progress reports on cannabis, the 2030 Agenda for sustainable develo...
Article
Full-text available
Article originally published in Cannabis Law Journal, under the title "High Compliance .. UN Treaties 'Reviewing The Reviewers'" in June 2022
Article
Full-text available
Le 2 décembre 2020, les Nations unies votaient la sortie du « cannabis » et de la « résine de cannabis » du Tableau IV annexé à la Convention unique sur les stupéfiants de 1961. Complexe et controversé, le vote et les recommandations de l’Organisation mondiale de la santé l’ayant motivé sont analysés et discutés. Après une revue et actualisation du...
Data
Supplemental materials to manuscript "Cannabis amnesia – Indian hemp parley at the Office International d’Hygiène Publique in 1935." | Contains: Table S1 Liste des préparations à base de chanvre indien indiquées par le Gouvernement égyptien comme employées par des toxicomanes. Figure S1 Reproduction of an excerpt from a list of standardised produ...
Chapter
Full-text available
"Naciones Unidas: situación regulatoria del Cannabis para usos medicinales y terapéuticos", capítulo 2 del Recopilatorio CannabisHub para la Subcomisión sobre cannabis medicinal del Congreso de los diputados "Cannabis medicinal en España", publicato por la Universitat Politècnica de Catalunya
Presentation
Full-text available
Cannabis: la legalizzazione è possibile! Come regolamentare la canapa in accordo con la convenzione unica sugli stupefacenti del 1961. Presentazione dello studio giuridico "High Compliance" en Bologna. | Traduzione: Leonardo Fiorentini & Enrico Fletzer. | Video: http://www.radioradicale.it/scheda/665282/cannabis-la-legalizzazione-e-possibile?i=4411...
Technical Report
Full-text available
In 2020, the International Narcotics Control Board (INCB) launched an opaque “Cannabis Control Initiative” whose scope, boundaries, and purposes were unclear. The initiative raised important concerns among world citizens, in particular organisations representing patients using Cannabis medicines and doctors of healthcare practitioners prescribing t...
Presentation
Full-text available
Présentation intitulée « L’approche post-prohibitionniste pour une réglementation durable du paka » lors du colloque de l'Université de la Polynésie française « Le Cannabis en Polynésie : entre Justice, Santé et Économie, une question de société » Vidéo : https://youtu.be/QvsvHrTfF_U?t=558 (à la 9ème minute environ)
Technical Report
Full-text available
On 21 April 2021, the herbal medicines “cannabis” and “cannabis resin” definitively ceased to appear in Schedule IV of the 1961 Single Convention on narcotic drugs (C61), where they had been listed since the entry into force of that treaty in 1964. The process to scientifically review and reschedule Cannabis-related controlled drugs had been launch...
Presentation
Full-text available
Le cannabis déconfiné & déclassifié : Recommandations de l'OMS & changement de classification du cannabis par l'ONU. Présentation lors des journées "le cannabis déconfiné - 18 joint" de la FPEA, 18 juin 2021.
Presentation
Full-text available
"Cannabis Nomenclature & Product Standardization." Presenter: Kenzi Riboulet-Zemouli. Topic: Identifying a coherent nomenclature cannabis products. Article to be Discussed: ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology, DOI: 10.1177/2050324520945797 – The SCC Journal Club meets monthly the first Friday of eve...
Book
Full-text available
Během minulého století postupně docházelo ke globálnímu sladění konopných politik. Rostlina konopí a jeho deriváty jsou zahrnuty v mezinárodním právním rámci upravujícím prohibici – a jsou „klasifikovány jako zdraví škodlivé a postrádají vědeckou nebo léčebnou hodnotu [...], přičemž pro tyto klasifikace neexistují dostatečné vědecké důkazy, zatímco...
Conference Paper
Full-text available
Pistes de réflexion autour des politiques publiques en matière de Cannabis ...autour de trois sigles ; contribution écrite à la Mission d'Information de l'Assemblée Nationale. – Complément écrit à l'Audition du 17 février 2021 à l'Assemblée Nationale (voir la vidéo : https://www.youtube.com/watch?v=HQc8SVRPT80 – voir les diapositives : https://www...
Technical Report
Full-text available
In March 2020, the International Narcotics Control Board (INCB) launched a “Cannabis Initiative” with the purpose of issuing “guidelines/manual of good practices on the international drug control requirements for the cultivation, manufacture and utilization of cannabis for medical and scientific purposes” and to “support Member States in complying...
Book
Full-text available
Hoy quedan ya relativamente pocos actores que nieguen el fracaso de la “guerra contra las drogas”, y son aún menos los que defienden su continuación. Existe, por tanto, un consenso amplio y compartido entre las diversas partes: el mundo necesita repensar las políticas del Cannabis. En una aldea mundial sobreconectada donde el comportamiento de nues...
Presentation
Full-text available
Pistes de réflexion autour des politiques publiques en matière de Cannabis: présentation utilisée lors de l'Audition du 17 février 2021 à l'Assemblée Nationale (vidéo, à 1h 3min : http://bit.ly/kenziAN2021 ou https://youtu.be/HQc8SVRPT80) dans le cadre de la mission d'information sur la réglementation et les impact des différents usages du cannabis...
Technical Report
Full-text available
Dans le cadre de sa réflexion sur la réglementation des usages du Cannabis, la Mission d’Information de l’Assemblée Nationale devrait prendre en compte les Cannabis Social Clubs, modèle associatif d’Économie Sociale et Solidaire, en complément d’un éventuel système marchand, et de l’autoproduction. Un tel modèle mixte (marchand + CSC) est à même de...
Data
Supplemental material (Appendices I, II, III, and IV) for the article " ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology" Drug Science Policy and Law, 2020
Experiment Findings
Full-text available
Scientifically identifying the ‘buds’, ‘tops’, ‘ganja’, ‘heads’ or ‘flowers’ is not an easy task, and consensus lacks on their precise botanical designation. ‘Flowers’ is the name for the preferred harvested parts bearing phytopharmaceutical ingredients, and is the most commonly encountered designation in literature. However, the findings of paper...
Presentation
Full-text available
Video recording: https://youtu.be/BHnBumHLXOE – Presentation on international medical cannabis law and the changes in scheduling recommended by the WHO ECDD (Expert Committee on Drug Dependence). Delivered at the Special 20th anniversary event of the IACM (International Association for Cannabinoid Medicines).
Presentation
Full-text available
A video recording is available at https://youtu.be/Im70ayRyb2U ||| Presentation in part based on the article "‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology" Drug Science Policy and Law 2020;6:1–37 https://www.researchgate.net/publication/343988256_'Cannabis'_ontologies_I_Conceptual_issues_with_Cannabis_and_ca...
Presentation
Full-text available
Ver video: https://www.youtube.com/watch?v=BG7I9mAX9tg Presentación para el tercer congreso CANNABMED, 6 de octubre 2020, Col·legi Oficial de Farmacèutics de Barcelona (COFB), Barcelona, España.
Research
Full-text available
The INCB is preparing a "guidelines/manual of good practices on the international drug control requirements for the cultivation, manufacture and utilization of cannabis for medical and scientific purposes" that "will support Member States in complying with the 1961 Single Convention." 1Since the establishment of such guidelines/manual represents a...
Technical Report
Full-text available
Early July 2020, the European Commission’s Directorate-General for Health and Food Safety announced that it might adopt a position in which food products containing cannabidiol (CBD) derived from Cannabis sativa L. (hemp plant) would not be authorized for sale in the European Union, being assimilated to medicines under control (“narcotic drugs”). T...
Technical Report
Full-text available
Analyse der vorläufigen Schlussfolgerungen der Europäischen Kommission zur Qualifizierung von Cannabidiol in Lebens- und Nahrungsmitteln als Betäubungsmittel. | übersetzt ins Deutsche (nicht-zertifizierte Übersetzung) | Original in English: CBD as a ‘narcotic’? Food for thought. https://www.researchgate.net/publication/343768923
Technical Report
Full-text available
In 2019 the WHO Expert Committee on Drug Dependence declared that “preparations of cannabis have shown therapeutic potential for the treatment of pain and other medical conditions such as epilepsy and spasticity associated with multiple sclerosis, which are not always controlled by other medications” as well as providing relief for “anorexia associ...
Conference Paper
Full-text available
Changes in the scope of control over cannabis: Cannabis, Traditional medicine & the 1961 Convention. Confusions and gaps in understanding surround the recommendations of the WHO Expert Committee on Drug Dependence regarding medicines made of cannabis or cannabis-related substances. This series of fact sheets seeks to bring light on the recommendati...
Conference Paper
Full-text available
Changes in the scope of control over cannabis: Clarifying recommendation #5 on CBD products. Confusions and gaps in understanding surround the recommendations of the WHO Expert Committee on Drug Dependence regarding medicines made of cannabis or cannabis-related substances. This series of fact sheets seeks to bring light on the recommendations, and...
Conference Paper
Full-text available
Changes in the scope of control over Cannabis: Clarifying the evidence behind the recommendations. Confusions and gaps in understanding surround the recommendations of the WHO Expert Committee on Drug Dependence regarding medicines made of cannabis or cannabis-related substances. This series of fact sheets seeks to bring light on the recommendation...
Preprint
Full-text available
Elements about the upcoming action to be taken by UN Commission on Narcotic Drugs on the WHO recommendations concerning the rescheduling of Cannabis and derived products in March 2020, and the proposal for a common position of European Member states at this occasion.
Presentation
Full-text available
The World Health Organization (WHO) is the leading standardization entity and public health referent globally in relation with Traditional and Complementary Medicines (TCM). Beside this role, WHO is also directly mandated by the International Drug Control Conventions (IDCC) as the provider of official scientific and independent assessments of drugs...
Data
Visual representation of the changes in international Cannabis scheduling recommended by the World Health Organization.
Preprint
Full-text available
The exemption of drugs used in industrial contexts is a core principle of the International Drug Control Conventions. The 1961 and 1971 Conventions only address medicines and the pharmaceutical sector – thus providing repeated statements that their provisions do not apply to “drugs” when used for any other purposes that medical and scientific ones....
Technical Report
Full-text available
Memo for State Parties. Changes in the scope of international control of medical Cannabis and cannabinoids. 4th inter-sessional meeting, 62nd Commission on Narcotic Drugs, June 24th, 2019.
Technical Report
Full-text available
Au vu de l’avancée des recherches scientifiques et de l’évolution du contexte international, les décideurs politiques français doivent se saisir du sujet de la régulation du cannabis à visée thérapeutique. La mise en place d’une régulation « à la française » au service du patient, dans un cadre réglementaire et/ou législatif précis, permettrait de...
Book
Full-text available
Updated toolkit available at www.cannabis2030.org – También en español: www.cannabis2030.org/es –––––– Subtitled "Recommendations for the implementation of Cannabis policies aligned with international Human Rights standards, the 2030 Agenda for Sustainable Development and the 2016 UNGASS outcome document", this report explains how the reform of hem...
Technical Report
Full-text available
From 2016 to 2019 the World Health Organization undertook a thorough review and assessment of Cannabis and cannabis-related substances. This report provides a basis to understand that assessment, providing information about the processes, stakeholders and history of Cannabis within the international drug control system.
Technical Report
Full-text available
From 2016 to 2019 the World Health Organization undertook a thorough review and assessment of Cannabis and cannabis-related substances. This one of the few substantial and official contributions provided for the second of the three Expert meetings dedicated to the review. The contribution points out important procedural, methodological and terminol...
Technical Report
Full-text available
In May 2018, FAAAT think & do tank submitted to the United Nations High Commissioner for Human Rights this contribution to its follow-up of the 2016 UNGASS (pursuant to resolution HRC 37/42). The document wondered if the victims of human rights violations generated by drug policies could demand and obtain reparation. Concision is due to limitations...
Technical Report
Full-text available
From 2016 to 2019 the World Health Organization undertook a thorough review and assessment of Cannabis and cannabis-related substances. This one of the few substantial and official contributions provided for the first of the three Expert meetings dedicated to the review, the "Pre-review" of Cannabidiol (CBD). Responsible under press legislation (V...
Technical Report
Full-text available
Dans le cadre de la Mission d'Information de l'Assemblée Nationale, relative à l’application d'une procédure de l’amende forfaitaire au délit d’usage illicite de stupéfiants.
Technical Report
Full-text available
Cette note argumentaire souhaite éclairer un point récurrent du débat à propos des effets psychotropes du Cannabis : Quid de l'impact et des conséquences d'une limitation du taux de THC ( delta-9-TétraHydroCannabinol ) en cas de régulation de la filière Cannabis ? Depuis quelques années, la question de la régulation du marché du Cannabis, notamment...
Conference Paper
Full-text available
Alors que la proposition de la Sénatrice Benbassa et du groupe EELV favorisent un État qui gèrerait l’ensemble de la filière du cannabis légal, les propositions alternatives suggèrent un marché entièrement privatisé. Pourtant, un entre-deux est possible, en s’inspirant de l’exemple uruguayen et des spécificités de terrain de la France : un modèle m...
Book
Alinhar as políticas da Canábis e do cânhamo com a Agenda 2030 para o Desenvolvimento Sustentável (na imprensa)

Network

Cited By

Projects

Projects (4)
Project
A research stream on the ontological backgrounds of Cannabis terms in science and policy.
Project
Cannabis : Reflexions autour des politiques publiques françaises en la matière
Project
Assess and inform international drug control policies for the diverse uses of Cannabis and its derivatives.